創業慧康(300451.SZ):公司已與浙大計算機創新研究院合作
格隆匯9月21日丨創業慧康(300451.SZ)近期在接待機構投資者調研時表示,公司已與浙大計算機創新研究院合作,在其授權範圍內使用相關的醫學知識庫及慧康-啟真醫療大模型。慧康-啟真大模型訓練的數據量已達到13萬多藥品知識及藥品説明書、1萬多種疾病知識、2萬多份指南文檔、4000多項手術知識內容、2000多項檢查檢驗知識、2000多份評估表內容,以及百萬級的醫患問答數據。
目前,公司利用浙江大學人工智能普適化平台基於類GPT算法的嵌入式臨牀決策支持系統CDSS已通過多家醫院、區域試點用户的使用,正式發佈;智能就醫助手已在浙江大學醫學院附屬婦產科醫院成功運行;產科全流程閉環的智能專科電子病歷也已在嘉興市婦幼保健院試點運行。醫療機構通過慧康啟真大模型和公司慧意GPT平台,可以以一個專業醫生的水平對病歷進行醫學專業的評估,並將結果實時反饋給醫生,實現臨牀病歷質量的全面改善,幫助醫護人員提高醫療質效,改善臨牀結果。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.